Zacks Investment Management’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-644
Closed -$597K 529
2020
Q4
$597K Sell
644
-50
-7% -$46.4K 0.01% 400
2020
Q3
$713K Sell
694
-37
-5% -$38K 0.01% 359
2020
Q2
$741K Sell
731
-142
-16% -$144K 0.02% 351
2020
Q1
$759K Sell
873
-413
-32% -$359K 0.02% 339
2019
Q4
$1.38M Buy
1,286
+348
+37% +$373K 0.03% 338
2019
Q3
$867K Sell
938
-128
-12% -$118K 0.02% 389
2019
Q2
$1.2M Buy
1,066
+30
+3% +$33.9K 0.02% 371
2019
Q1
$1.41M Buy
1,036
+33
+3% +$44.8K 0.03% 324
2018
Q4
$1.16M Buy
+1,003
New +$1.16M 0.03% 322
2018
Q2
Sell
-426
Closed -$492K 565
2018
Q1
$492K Sell
426
-11
-3% -$12.7K 0.01% 459
2017
Q4
$518K Buy
437
+113
+35% +$134K 0.01% 467
2017
Q3
$436K Hold
324
0.01% 459
2017
Q2
$262K Sell
324
-290
-47% -$235K 0.01% 506
2017
Q1
$378K Buy
+614
New +$378K 0.01% 478